Two islands, Gyodongmyeon and Samsanmyeon, which contain 24.5% (15.1%–30.9%) of patients with malaria among all patients in Ganghwa with malaria, were selected for the seroepidemiological study to evaluate the CSP antigen. This evidence concerns the gene DNAJC5 and malaria.